Exhibition Info.

Search by Exhibitors

All 151 exhibitors
111

641
110 XENOSYS
XENOSYS

817
109 Yours Dental Co., Ltd.
Yours Dental Co., Ltd.

Innovation in Precision Diagnosis: Launching T-Bite, the Maximum Bite Force Measurement Device As a leading distributor that has consistently supplied high-quality dental materials and equipment from Germany and the U.S. to the Korean market, we are proud to introduce our first manufactured product: T-Bite. By integrating years of industry expertise, T-Bite is set to establish a new standard in the precision diagnosis market. Leveraging our powerful sales network and significant influence across South Korea, we are spearheading the market entry of this innovative device. Beyond simple distribution, we provide comprehensive support—including professional seminars and hands-on courses—to ensure that new technologies can be immediately applied in clinical practice. Our mission is to empower dentists with accurate diagnostic tools, provide patients with optimal treatment outcomes, and offer our global partners opportunities for mutual growth. Our product portfolio includes:- T-Bite : Maximum Bite Force Measurement Device (Yours Dental Co., Ltd. S.Korea)- T-Scan Novus : Distal Occlusion Analysis System (Tekscan Inc., USA)- Care-Wiz : Ion Implantation (with Hot & Cold, Ultra Sonic Functions) Device for TMD & Cosmetics (Yours Dental, S.Korea)- Endo-Wiz : Radio Frequency Endo Treatment Device (Yours Dental, S.Korea)- Grandio : Universal nano-hybrid restorative material (VOCO GmbH, Germany)- Quicklear Brackets : Ceramic Self-ligation brackets (FORESTADENT, Germany)- 25/03 21mm : Niti Rotary File for Minimally Invasive Shaping (Bassi Endo, Brazil)

472
108 GC KOREA
GC KOREA

GC produces about 600 types of products and sells them in more than 100 countries around the world. Since each overseas market has different requirements, we operate overseas branches in regions such as Europe, the United States, and Asia accordingly.In addition, GC is making every effort to carry out its local activities and also fulfills its obligations as a local company by actively participating in the dental industry associations of each country.In this way, GC manufactures products in the optimal locations around the world, meeting the demand of relatively large markets such as Europe and the United States.We are also building a strong presence in the rapidly growing Chinese and Indian markets.All three major manufacturing plants have obtained ISO 13485 certification, and awareness of the high quality of the products continues to expand in the global market.

635
107

736
106 Cross-M Co.
Cross-M Co.

571
105 CRYSTALOPTIC Co.,Ltd
CRYSTALOPTIC Co.,Ltd

Crystal Optic Co., Ltd. was established in Incheon, South Korea, in 1992, beginning as an optical retail business with a network of stores across Seoul and the Gyeonggi region.In 1998, the company successfully researched and developed its own medical loupes, achieving full domestic production in Korea. As a pioneer in what was then an emerging market, Crystal Optic played a leading role in introducing and supplying Korean-made medical loupes to local healthcare professionals.Through continuous research and product development, the company introduced ultra-compact medical headlights as well as Korea’s first individually customized TTL (Through-The-Lens) loupes.Drawing on decades of experience in the optical industry, Crystal Optic combines extensive knowledge of ophthalmic optics with specialized expertise in medical loupes. From carefully selected lenses and precise measurements to manufacturing and personalized fitting, we provide professional support throughout the entire process.In 2012, Crystal Optic launched its medical loupe brand, SURGELOUP.Today, the second generation continues the SURGELOUP family business, combining long-established technical expertise with modernized systems and close, face-to-face customer service. Through this approach, we continue to develop and strengthen SURGELOUP as a sustainable and trusted medical loupe brand.

840
104 Keeps Biopharma
Keeps Biopharma

649
103 THOMASTONE
THOMASTONE

Thomastone Co., Ltd. is a digital healthcare company dedicated to creating new value in oral healthcare through artificial intelligence (AI). By integrating remote oral health monitoring with dental plaque visualization technology, the company provides a comprehensive solution that enables users to assess and systematically manage their oral health anytime and anywhere.Its key services include a personalized oral healthcare solution that combines an AI-powered oral health monitoring platform with dental plaque-disclosing products DentiHygiene, a digital system for managing dental hygiene education, clinical training, and performance assessment and a professional community platform that connects dental hygienists with local communities.Through its corporate research institute, Thomastone collaborates with domestic and international dental schools, medical schools, dental hospitals, and public institutions to conduct research and development, clinical validation, and community-based field studies. Through these initiatives, the company aims to advance connected care and value-based healthcare while building an environment in which everyone can access professional oral healthcare as part of their daily lives.

556
102 Purgo Biologics Inc.
Purgo Biologics Inc.

Purgo Biologics Inc. is a South Korean biomaterials company with over twenty years of dedicated expertise in the development and manufacturing of dental regenerative solutions, with particular emphasis on bone graft substitutes and barrier membranes.Anchored in its guiding principle, “Leading the New Standard of Regeneration,” the company pursues the advancement of clinically reliable and biologically optimised materials designed to support predictable regenerative outcomes in dental applications.Based on these clinical results, Purgo has published over 80 scientific papers, including SCI-level journals, and has proven product excellence through regulatory approvals in more than 50 countriesA recent nationwide survey conducted by the ‘Moreden’ professional dental community, involving 1,002 practitioners in South Korea, ranked Purgo as the Dentists’ No.1 Choice in Bone Grafts, reflecting strong practitioner confidence and widespread clinical adoption.THE Graft (porcine xenograft), the company’s flagship product, exhibits favorable clinical efficacy and is recognized for its superior biological performance. Building on this success, THE Graft Collagen (porcine xenograft with Collagen) achieved a significant regulatory milestone as the first in South Korea and the second worldwide in its category to be certified under the European Union Medical Device Regulation (EU MDR).This achievement underscores the robustness of Purgo’s translational research work and its unwavering commitment to the most stringent international standards in quality management and regulatory compliance.Purgo continues to strengthen its position as a leading global innovator in dental biomaterials through the expansion of a comprehensive product portfolio including advanced bone grafts, membranes and suture.

261